Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3724254rdf:typepubmed:Citationlld:pubmed
pubmed-article:3724254lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3724254lifeskim:mentionsumls-concept:C0036646lld:lifeskim
pubmed-article:3724254lifeskim:mentionsumls-concept:C0031676lld:lifeskim
pubmed-article:3724254lifeskim:mentionsumls-concept:C0024643lld:lifeskim
pubmed-article:3724254lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:3724254lifeskim:mentionsumls-concept:C0596040lld:lifeskim
pubmed-article:3724254lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:3724254lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:3724254pubmed:issue3lld:pubmed
pubmed-article:3724254pubmed:dateCreated1986-8-13lld:pubmed
pubmed-article:3724254pubmed:abstractTextLipid extracts of the human cataractous and normal lenses were analyzed by thin-layer chromatography (TLC) using a solvent system consisting of CHCl3/CH3OH/CH3COOH/H2O (50:25:7:3 by vol.). A novel phospholipid having a Rf intermediate between phosphatidyl ethanolamine (PE) and phosphatidyl serine (PS) was detected besides the four major phospholipids viz., PE, PS, phosphatidyl choline (PC) and sphingomyelin (SP). The novel phospholipid was found to be molybdenum positive and ninhydrin negative having a characteristic fluorescence of Schiff-base conjugate formed between PE, malondialdehyde (MDA) and PS. It was possible to resolve this adduct into PE and PS after acid hydrolysis using two dimensional TLC with CHCl3/CH3OH/NH3 (7 M) (65:25:4 by vol.) as the second solvent. In cataract PE . MDA . PS adduct increased significantly as did diene conjugates and MDA. In plasma membrane lipid extract of cataractous lenses there was a marked increase in fluorescence at 460 nm when excited at 365 nm showing a characteristic fluorescence of a typical Schiff-base conjugate. The evidence suggests that peroxidation of lenticular plasma membrane lipids is one of the molecular mechanisms involved in cataract in the human.lld:pubmed
pubmed-article:3724254pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3724254pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3724254pubmed:languageenglld:pubmed
pubmed-article:3724254pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3724254pubmed:citationSubsetIMlld:pubmed
pubmed-article:3724254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3724254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3724254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3724254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3724254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3724254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3724254pubmed:statusMEDLINElld:pubmed
pubmed-article:3724254pubmed:monthMaylld:pubmed
pubmed-article:3724254pubmed:issn0047-6374lld:pubmed
pubmed-article:3724254pubmed:authorpubmed-author:BhuyanK CKClld:pubmed
pubmed-article:3724254pubmed:authorpubmed-author:BhuyanD KDKlld:pubmed
pubmed-article:3724254pubmed:authorpubmed-author:ColesR SRSlld:pubmed
pubmed-article:3724254pubmed:authorpubmed-author:MasterR WRWlld:pubmed
pubmed-article:3724254pubmed:issnTypePrintlld:pubmed
pubmed-article:3724254pubmed:volume34lld:pubmed
pubmed-article:3724254pubmed:ownerNLMlld:pubmed
pubmed-article:3724254pubmed:authorsCompleteYlld:pubmed
pubmed-article:3724254pubmed:pagination289-96lld:pubmed
pubmed-article:3724254pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:meshHeadingpubmed-meshheading:3724254-...lld:pubmed
pubmed-article:3724254pubmed:year1986lld:pubmed
pubmed-article:3724254pubmed:articleTitleMolecular mechanisms of cataractogenesis: IV. Evidence of phospholipid . malondialdehyde adduct in human senile cataract.lld:pubmed
pubmed-article:3724254pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3724254pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3724254pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3724254lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3724254lld:pubmed